On this page you can find information about A day with… Cochrane Co-production Methods Group which took place on 24 February 2026.
Programme (24 February 2026)
Session 2: Working together to advance co-production of evidence synthesis
Discussion board
Introductory videos
Image
| Image
|
Image
| Image
|
Image
| Image
|
Meet the Board members
In this virtual facewall you can watch members of the Cochrane Co-production Methods Group Board introduce themselves in brief videos.
Session 1: How to co-produce an evidence synthesis
Recording and presentation slides
This session introduced the concept of co-production of evidence syntheses. Presentations covered key definitions, why patient and public involvement (PPI) is important for evidence syntheses, introduced the ACTIVE framework for describing PPI in evidence synthesis, and provided a series of examples of co-produced evidence syntheses.
Chairperson: Maureen Smith
Presentation 1: Introduction to co-production of evidence synthesis | Presentation 2: Engaging people with experience of homelessness in a scoping review | Presentation 3: Working together to understand evidence in musculoskeletal conditions |
Image
| Image
| Image
|
Alex Todhunter-Brown Professor of Evidence Synthesis at Glasgow Caledonian University, Scotland, Co-convener of the Cochrane Co-production Methods Group, and Co-lead of the Cochrane Heart, Stroke and Circulation Thematic Group. Alex has conducted research focused on patient, public and wider interest-holder involvement in evidence synthesis. | Andrea Tricco A Scientist and the Executive Director of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto. She is a Professor at the University of Toronto in the Dalla Lana School of Public Health & Institute of Health Policy, Management, and Evaluation. She is Co-Editor in Chief of the Journal of Clinical Epidemiology. | Lyndsay Alexander Associate Professor in the School of Health at Robert Gordon University, Aberdeen, Scotland and Co-Director of the JBI Scottish Centre for Evidence-based Practice. |
Presentation 4: Co-production in practice: two evidence synthesis partnerships with parents | ||
Image
| ||
| Kate Boddy Research fellow for the Patient and Public Involvement Team within NIHR PenARC. She leads PPI on two NIHR evidence synthesis programmes; ISCA Evidence and Exeter PRP Evidence Review Facility as part of her PPI work for ISCA Evidence she co-leads the national PPI community of practice. |
Session 2: Working together to advance co-production of evidence synthesis
Our international panel answered questions and discussed topics raised by attendees from their perspectives as citizens, researchers, evidence synthesis producers, and organizational leaders. There was a lively discussion highlighting the challenges and opportunities for co-production of evidence synthesis.
Moderator: Alex Todhunter-Brown
Panel members:
Image
| Image
| Image
|
Sophie Staniszweska Sophie is a Professor of Patient and Public Involvement and Engagement and Experiences of Care at Warwick Medical School, England and is a Clarivate highly cited researcher. Sophie leads several studies developing the evidence base for PPIE practice and is Co-Editor in Chief of Research Involvement and Engagement. | Maureen Smith Maureen Smith's unwavering commitment to evidence-based medicine and patient/citizen engagement in evidence synthesis stems from her lived experience with the health system subsequent to a rare disease diagnosis in childhood. She is the co-convenor of Cochrane’s Co-Production Methods group and chaired Cochrane’s Consumer Network Executive from 2019-2024. Maureen is involved in several global advisory committees and projects such as the Evidence Synthesis Infrastructure Collaborative. | April English April is Cochrane’s Patient and Public Involvement Manager. April's experience includes patient and public involvement, knowledge translation and implementation, health promotion, and policy. A rare disease patient herself, she is passionate about working alongside those impacted to ensure health evidence makes a real difference. |
Image
| Image
| |
| John Lavis John is interested in how we can design and implement the methods and process innovations that will move us collectively to policy-scale, AI-enabled living evidence syntheses on all of the big questions of our time, including how we adjust co-production models to such global public goods and to locally contextualized versions that are produced in timely, demand-driven ways. He is director of the McMaster Health Forum (which continues to learn and improve in how it supports co-production), a professor at McMaster University, and an advisor to the Wellcome Trust on the Evidence Synthesis Infrastructure Collaborative. | Ndi Euphrasia Ebai-Atuh Euphrasia is a resource mobilizer who believes in a world where policy making and everyday actions are informed by evidence produced in a diverse and inclusive manner. As a co-founder of Cameroon Consumer Service Organisation, she has designed, implemented and collaborated in several patient and public initiatives within evidence syntheses health and education initiatives. |
Discussion board
As part of our A day with… Cochrane Co-production Methods Group event, we invited participants to submit questions for our speakers and the Group’s co-convenors via this discussion board .
Additional links and resources
Additional information and learning resources can be found at the Cochrane's Co-production Methods Group:
https://methods.cochrane.org/co-production/resources-and-links
